Weil John D's Form 4 filing
Allied Healthcare Products Inc (AHPI) · filed Nov 30, 2021
- Accession no.
- 0001415889-21-005587
- Filed
- Nov 30, 2021
- Trade date
- Nov 11-26, 2021
- Filing delay
- 19 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.15M. It was filed 19 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weil John DCIK 0000904314 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 | Common Stock | SSaleDisposed | −69,249 | $8.44F1 | −$584,461.56 | 25,178 | Indirect | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −59,101 | $8.47F1 | −$500,585.47 | 0 | Indirect | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −7,514 | $8.06F1 | −$60,562.84 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common stock | AGrant or awardAcquired | +750 | $0.00 | $0 | 750 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 3 transactions in Table I.